Sarepta Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, MA
SRPT chart
What traders are saying about $SRPT
Latest postsSarepta Therapeutics, Inc. news
- Sarepta Therapeutics, Inc. (SRPT) stock price, news, quote and history
Yahoo Finance Singapore ·
- Sarepta Therapeutics to Present at Upcoming Investor Conferences - October 26, 2026
BioSpace ·
- Sarepta Therapeutics, Inc. (SRPT) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- SRPT Stock Climbs After Sarepta Seeks Permanent FDA Nod For Two Duchenne Therapies
Stocktwits ·
- How Investors May Respond To Sarepta Therapeutics (SRPT) DM1 Therapy Progress
Simply Wall Street ·
- Sarepta Therapeutics to Present at Upcoming Investor Conferences
Yahoo Finance ·
- Sarepta schedules third-quarter results. TD Cowen targets Sarepta Therapeutics stock at USD 17
ad-hoc-news.de ·
- Sarepta Therapeutics, Inc. Estimates – NASDAQ:SRPT
TradingView ·
- How Much Downside Is Left In Moderna Stock?
trefis.com ·
- Is Sarepta Therapeutics (SRPT) Undervalued Following New SRP 1003 Preclinical Data?
Simply Wall Street ·
- Sarepta Therapeutics to Announce Third Quarter 2026 Financial Results
Yahoo Finance ·
- TD Cowen keeps USD 17 target for Sarepta Therapeutics stock
ad-hoc-news.de ·
Sarepta Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $1.86B | $1.79B | $1.14B | $843.8M |
| Net income | -$713.4M | $235.2M | -$536.0M | -$703.5M |
| Diluted EPS | $-7.13 | $2.34 | $-5.80 | $-8.03 |
| Total assets (year end) | $3.35B | $3.96B | $3.26B | $3.13B |
| Cash and equivalents (year end) | $801.3M | $1.10B | $428.4M | $966.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Sarepta Therapeutics, Inc.
- Ticker
- SRPT (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 873303
- Former names
- Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
Frequently asked questions
What exchange is Sarepta Therapeutics, Inc. listed on?
Sarepta Therapeutics, Inc. trades on the Nasdaq under the ticker symbol SRPT.
What industry is Sarepta Therapeutics, Inc. in?
Sarepta Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Sarepta Therapeutics, Inc. headquartered?
Sarepta Therapeutics, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Sarepta Therapeutics, Inc.'s fiscal year end?
Sarepta Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Sarepta Therapeutics, Inc. report?
Sarepta Therapeutics, Inc. reported $1.86B in revenue for calendar year 2025, according to its SEC filings.